Reverse iontophoresis: Noninvasive glucose monitoring in vivo in humans

被引:101
作者
Rao, G
Guy, RH
Glikfeld, P
LaCourse, WR
Leung, L
Tamada, J
Potts, RO
Azimi, N
机构
[1] UNIV CALIF SAN FRANCISCO, DEPT PHARM, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA
[3] ISRAEL INST BIOL RES, IL-70450 NESS ZIONA, ISRAEL
[4] UNIV MARYLAND, DEPT CHEM, BALTIMORE, MD 21228 USA
[5] CYGNUS THERAPEUT SYST, REDWOOD CITY, CA 94063 USA
关键词
iontophoresis; ''reverse iontophoresis''; electroosmosis; glucose monitoring; skin permeation;
D O I
10.1023/A:1016271301814
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose: To demonstrate that ''reverse iontophoresis'' can be used to noninvasively obtain information about systemic glucose levels in vivo in humans. Methods. The passage of current across the skin in vivo drives ions into the tissue, from the electrode chambers positioned on the skin surface, and simultaneously pulls ions from the body in the opposite direction. Because of the net negative charge on the skin, under normal conditions, the membrane is permselective to cations, and a potential gradient also results, therefore, in electroosmotic convection of Solvent in the direction of counterion flow (i.e., from anode to cathode). Thus, it is also possible to enhance the transport of polar, yet uncharged, species using iontophoresis: In an earlier study, the in vitro extraction of glucose, by ''reverse iontophoresis'' was established, and extension of the approach to an in vivo model was indicated. The idea has therefore been further explored in vivo in humans. Results. Using small, simple, prototypical electrode chambers, attached to the ventral forearm surface, direct current iontophoresis at 0.25 mA/cm(2) for periods of up to 1 hour, and a sensitive analytical procedure to measure the quantities of glucose extracted, it has been shown that iontophoretic sampling of glucose is feasible. However, the shorter periods (15 minutes or less) of extraction considered yield results which are ''contaminated'' (it is believed) by glucose that is a product of lipid metabolism within the skin. While this material is expected to complicate the initial calibration of the approach, the problem is effectively resolved within one hour, by which time the glucose arriving in the electrode chambers on the skin surface is expected to directly reflect the subcutaneous tissue concentration. Conclusions. Based upon these initial observations, further investigation can now be directed towards optimization of electroosmotic flow and sampling time, improved reproducibility and the development of a practical assay methodology.
引用
收藏
页码:1869 / 1873
页数:5
相关论文
共 12 条
[1]  
BURNETTE RR, 1989, TRANSDERMAL DRUG DEL, P247
[2]  
Crank J., 1976, MATH DIFFUSION
[3]  
Glikfeld P., 1994, U.S. Pat, Patent No. [5,279,543, 5279543]
[4]   IONTOPHORETIC DELIVERY OF AMINO-ACIDS AND AMINO-ACID DERIVATIVES ACROSS THE SKIN INVITRO [J].
GREEN, PG ;
HINZ, RS ;
CULLANDER, C ;
YAMANE, G ;
GUY, RH .
PHARMACEUTICAL RESEARCH, 1991, 8 (09) :1113-1120
[5]  
GUY R, 1994, Patent No. 5362307
[6]  
LACOURSE WR, 1993, ANALUSIS, V21, P181
[7]   SKIN BIOLOGICAL ISSUES IN ELECTRICALLY ENHANCED TRANSDERMAL DELIVERY [J].
LEDGER, PW .
ADVANCED DRUG DELIVERY REVIEWS, 1992, 9 (2-3) :289-307
[8]  
MILLER JC, 1986, STATISTICS ANAL CHEM, P100
[9]   THE ROLE OF ELECTROOSMOTIC FLOW IN TRANSDERMAL IONTOPHORESIS [J].
PIKAL, MJ .
ADVANCED DRUG DELIVERY REVIEWS, 1992, 9 (2-3) :201-237
[10]   REVERSE IONTOPHORESIS - DEVELOPMENT OF A NONINVASIVE APPROACH FOR GLUCOSE MONITORING [J].
RAO, G ;
GLIKFELD, P ;
GUY, RH .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1751-1755